Skip to main content

ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and diluent syringe Cancelled under Section 30(1)(c) of the Act

Product name
ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and diluent syringe
ARTG
43725
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site